Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hutchmed China Ltd ADR
(NQ:
HCM
)
17.17
-0.09 (-0.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hutchmed China Ltd ADR
< Previous
1
2
3
4
5
6
7
8
Next >
HUTCHMED Initiates Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Colorectal Cancer
December 19, 2022
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
December 16, 2022
From
Prenetics Limited
Via
GlobeNewswire
Deutsche Bank ADR Investor Conference: Presentations Now Available for On-Demand Viewing
November 18, 2022
Company Executives Shared Vision and Answered Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Hutchmed Plans Strategic Focus Shift On Late-Stage Programs, Details Not Disclosed
November 15, 2022
Via
Benzinga
HUTCHMED Cancer Med Cuts Death Risk By 34% In Metastatic Colorectal Cancer
September 08, 2022
Via
Benzinga
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 28, 2022
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.
Via
Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
November 15, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals
November 14, 2022
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 14, 2022
Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...
Via
Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Hutchmed-Lilly Partnered Gastric Cancer Drug Shows Mixed Results In Phase 3 Study
November 14, 2022
HUTCHMED (China) Limited (NASDAQ: HCM) announced initial results from FRUTIGA Phase 3 trial of fruquintinib combined with paclitaxel in 703 Chinese patients with advanced gastric or gastroesophageal...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 14, 2022
Welcome back and get ready for the week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!
Via
InvestorPlace
HUTCHMED Announces Positive Topline Result in Fruquintinib Phase III FRUTIGA Study in Second-Line Gastric Cancer in China
November 13, 2022
From
HUTCHMED (China) Limited
Via
GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2022
November 09, 2022
From
Virtual Investor Conferences
Via
GlobeNewswire
HUTCHMED Initiates a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in China
October 27, 2022
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.
Via
Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
HUTCHMED Initiates a Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
October 10, 2022
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...
Via
Benzinga
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 2022
Gainers
Via
Benzinga
Groupon, Spectrum Brands, Adobe And Other Big Losers From Thursday
September 16, 2022
U.S. stocks closed lower with the Nasdaq 100 dropping around 200 points on Thursday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
7 Chinese Stocks to Sell While You Still Can
September 02, 2022
These Chinese stocks have had a rough outing at the stock markets of late, as their underlying businesses buckle under the economic pressure
Via
InvestorPlace
Week in Review: Hansoh In-licenses Endometriosis/Fibroid Therapy in $170 Million Deal
August 13, 2022
Other funding deals for drug discovery, R&D, gene editing.
Via
Talk Markets
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
Via
Benzinga
Goldman Sachs Maintains Neutral Rating for HUTCHMED: Here's What You Need To Know
August 09, 2022
Goldman Sachs has decided to maintain its Neutral rating of HUTCHMED (China) (NASDAQ:HCM) and raise its price target from $14.00 to $16.00. Shares of HUTCHMED (China) are trading down 5.74% over the...
Via
Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.